Re:Histamine H2 receptor blockers use in patients with cardiovascular disease treated with aspirin
CCBYNCOpen access
Rapid response to:
Research
Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study
Re:Histamine H2 receptor blockers use in patients with cardiovascular disease treated with aspirin
We appreciate the comments by Fernandez-Fernandez et al. to our
article and find their discussion regarding differences in the effect of
individual H2-blockers interesting. However, due to the relatively small
number of patients receiving H2-blockers in our study, we were not able to
include an analysis of differences between individual H2-blockers.
Competing interests:
No competing interests
10 June 2011
Mette G. Charlot
Research fellow
Erik L Grove, Christian Torp-Pedersen, and Gunnar Gislason
Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark
Rapid Response:
Re:Histamine H2 receptor blockers use in patients with cardiovascular disease treated with aspirin
We appreciate the comments by Fernandez-Fernandez et al. to our
article and find their discussion regarding differences in the effect of
individual H2-blockers interesting. However, due to the relatively small
number of patients receiving H2-blockers in our study, we were not able to
include an analysis of differences between individual H2-blockers.
Competing interests: No competing interests